Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) is a publicly traded the market company. As of October 30, 2026, CUVL trades at $5.11 with a market cap of $255.97M and a P/E ratio of 0.00. CUVL moved +0.00% today. Year to date, CUVL is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $4.88 to $8.20. Rallies surfaces CUVL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CUVL combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $5.11 |
| Market Cap | $255.97M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.04% |
| 52-Week High | $8.20 |
| 52-Week Low | $4.88 |
| Volume | 1.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
CUVL analyst coverage data. Average price target: $0.00.